The Hartford, Conn.-based insurer’s decision to leave 11 of its 15 state exchanges next year is “credit positive,” as it lowers the insurer’s “earnings drag from unprofitable products,” according to the report. Moody’s also said the exit decreases the insurer’s exposure to poor business many insurers are facing on the exchanges.
Moody’s said the loss of exchange enrollees will not heavily impact Aetna’s business or revenue. In addition, Moody’s does not think the insurer’s exit will affect the outcome of its litigation with the Department of Justice, which sued to block its $37 billion acquisition of Louisville, Ky.-based Humana in July.
More articles about payer issues:
Tennessee commissioner: State exchange on verge of collapse
Utah unconcerned about Humana’s depature
Will ACA premium increases influence races for US Senate seats?
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
